missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Clofibrate, Mikromol™
Description
Clofibrate
Specifications
Specifications
| Nom chimique ou matériau | Ethyl clofibrate |
| CAS | 637-07-0 |
| Noms d’analytes ou de composants | Ethyl clofibrate |
| Conditions d’expédition | Température ambiante |
| Formule moléculaire | C12 H15 Cl O3 |
| Certifications/Conformité | ISO 17025 |
| Synonyme | Clofibrate, Ethyl 2-(4-chlorophenoxy)-2-methylpropionate, 2-(4-Chlorophenoxy)-2-methyl-propanoic acid ethyl ester, Propionic acid, 2-(p-chlorophenoxy)-2-methyl-, ethyl ester (6CI,8CI), 2-(4-Chlorophenoxy)isobutyric acid ethyl ester, 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester, AY 61123, Abitrate, Amotril, Anparton, Apolan, Arteriosan, Artevil, Ateculon, Ateriosan, Atheropront, Atromid S, Atromidin, Azionyl, Bioscleran, CPIB, Cartagyl, Claripex, Claripex CPIB, Clobren SF, Clofibrat, Clofinit, ECPIB, EPIB, Ethyl 2-(4-chlorophenoxy)isobutyrate, Ethyl 2-(p-chlorophenoxy)-2-methylpropionate, Ethyl 2-(p-chlorophenoxy)isobutyrate, Ethyl clofibrate, Ethyl p-chlorophenoxyisobutyrate, Hyclorate, ICI 28257, Lipavil, Lipavlon, Lipomid, Liprinal, Miscleron, Misclerone, NSC 79389, Neo-Atromid, Normet, Normolipol, Recolip, Regelan, Serotinex, Sklerepmexe, Sklero-Tablinene, Sklerolip, Skleromexe, Ticlobran, Xyduril, p-Chlorophenoxyisobutyric acid ethyl ester, Ethyl alpha-(4-chlorophenoxy)-alpha-methylpropionate, Ethyl alpha-(4-chlorophenoxy)isobutyrate, Ethyl alpha-(p-chlorophenoxy)-alpha-methylpropionate, Ethyl alpha-(p-chlorophenoxy)isobutyrate |
| Formule InChI | InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3 |
| SMILES | CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 |
| Nom IUPAC | 2-(4-chlorophénoxy)-2-méthylpropanoate d’éthyle |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?